Latest AI and machine learning research in other cancers for healthcare professionals.
Accurate classification of BRCA1 and BRCA2 variants is essential for cancer risk assessment and ther...
DNA extracted from tissue samples typically derive from of a complex mixture of cell types. Without ...
We present Meta-D, an architecture that explicitly leverages categorical scanner metadata such as MR...
Glioblastoma exhibits diverse, infiltrative, and patient-specific growth patterns that are only part...
Clear cell renal cell carcinoma (ccRCC) is the leading cause of kidney cancer-related death, but how...
Accurate brain tumor typing requires integrating heterogeneous clinical evidence, including magnetic...
Glioblastoma exhibits diverse, infiltrative, and patient-specific growth patterns that are only part...
Summary Background Once the treatment starts, early prediction of treatment benefit and its correlat...
The development and validation of prognostic and predictive biomarkers in breast cancer is limited b...
Background: N4-acetylcytidine (ac4C) modification plays a critical role in cancer development. Explo...
While multimodal survival prediction models are increasingly more accurate, their complexity often r...
Breast cancer is the most frequently diagnosed malignancy among women worldwide and a leading cause ...
Purpose: Castration-resistant prostate cancer (CRPC) is characterized by marked clinical heterogenei...
Differences in microbiome composition profoundly influence drug response, yet methods to model the m...
Study Objectives Automated sleep staging underpins clinical sleep assessment and translational neuro...
The spatial organization of the tumor immune microenvironment (TIME) drives hepatocellular carcinoma...
Accurate brain tumor diagnosis requires models to not only detect lesions but also generate clinical...
Accurate prediction of malignancy in renal tumors is crucial for informing clinical decisions and op...
Background: Although deep learning models have improved individual PET analysis, image processing an...
Therapeutic target discovery remains a critical yet intuition-driven bottleneck in drug development,...
Deep intracranial tumors situated in eloquent brain regions controlling vital functions present crit...